retatrutide phase 3 triumph 🚨 HOT OFF THE PRESS: data has arrived — and the obesity medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average Retatrutide Shows Strong Weight Loss

40 (7), BSR20200316

I felt lighter, slimmer, and more energetic each day

The peptide down-regulated oxidative phosphorylation, suppressed MYC target genes, and attenuated PI3K-AKT-mTOR signalingpathways classically inhibited in validated lifespan-extending interventions

Better workout endurance and recovery

In a double-blind, parallel-group trial, the researchers randomly assigned 72 obese people to receive semaglutide or placebo

However, several concerns have been raised by medical professionals and researchers: Changes to Moles and Skin Lesions: One of the most significant concerns is the potential for Melanotan to cause changes in moles